Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Change in Cash (2016 - 2025)

Historic Change in Cash for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $1.9 million.

  • Axogen's Change in Cash rose 45407.97% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 12605.76%. This contributed to the annual value of -$3.5 million for FY2024, which is 12241.3% down from last year.
  • Per Axogen's latest filing, its Change in Cash stood at $1.9 million for Q3 2025, which was up 45407.97% from $1.9 million recorded in Q2 2025.
  • Axogen's 5-year Change in Cash high stood at $15.5 million for Q2 2023, and its period low was -$18.2 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Cash was -$70000.0 (2023), whereas its average is -$1.5 million.
  • As far as peak fluctuations go, Axogen's Change in Cash plummeted by 564882.35% in 2021, and later surged by 1280285.71% in 2024.
  • Over the past 5 years, Axogen's Change in Cash (Quarter) stood at -$14.1 million in 2021, then soared by 106.87% to $966000.0 in 2022, then crashed by 107.25% to -$70000.0 in 2023, then surged by 12802.86% to $8.9 million in 2024, then plummeted by 79.01% to $1.9 million in 2025.
  • Its Change in Cash was $1.9 million in Q3 2025, compared to $1.9 million in Q2 2025 and -$9.5 million in Q1 2025.